Please wait while we open this resource.
K
Clinical reviews
CENTRAL VENOUS PRESSURE (CVP)
Olfa Hamzaoui and Jean-Louis Teboul
PDF20223 pages561 KB
The article highlights the declining preference for CVP as a guide for fluid therapy, particularly in septic patients, following updated guidelines. Despite this, CVP remains a crucial hemodynamic variable that reflects right-ventricular function and organ perfusion pressure. Proper measurement techniques are essential for accurate interpretation, as errors can lead to mismanagement of fluid therapy. The authors stress the need for clinicians to understand the implications of CVP in managing critically ill patients.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
LEFT VENTRICULAR-ARTERIAL COUPLING IN SEPTIC SHOCK: A PHYSIOLOGICAL REVIEW
Same clinical topic · Critical Care
CENTRAL VENOUS PRESSURE REVISITED: PHYSIOLOGY, PITFALLS, MISCONCEPTIONS, AND MODERN CLINICAL INTERPRETATION IN CRITICAL CARE
Same clinical topic · Critical Care
HOW I PERSONALIZE FLUID THERAPY IN SEPTIC SHOCK?
Same clinical topic · Critical Care
PRINCIPLES OF FLUID MANAGEMENT
Same clinical topic · Critical Care
ANEMIA OF CRITICAL ILLNESS: A CONCISE DEFINITIVE REVIEW IN CRITICAL CARE
Same clinical topic · Critical Care
NON-INTERVENTIONAL FOLLOW-UP VERSUS FLUID BOLUS IN RESPONSE TO OLIGURIA IN HEMODYNAMICALLY STABLE CRITICALLY ILL PATIENTS: A RANDOMIZED CONTROLLED PILOT TRIAL
Same clinical topic · Critical Care
LONG-TERM EFFECTS OF RESTRICTION OF INTRAVENOUS FLUID IN ADULT ICU PATIENTS WITH SEPTIC SHOCK
Same clinical topic · Critical Care
ASSOCIATION BETWEEN COMBINATION ANTIBIOTIC THERAPY AS OPPOSED TO MONOTHERAPY AND OUTCOMES OF ICU PATIENTS WITH PSEUDOMONAS AERUGINOSA VENTILATOR-ASSOCIATED PNEUMONIA: AN ANCILLARY STUDY OF THE IDIAPASON TRIAL
Same clinical topic · Critical Care
INTERFERON GAMMA - 1B FOR THE PREVENTION OF HOSPITAL - ACQUIRED PNEUMONIA IN CRITICALLY ILL PATIENTS: A PHASE 2, PLACEBO - CONTROLLED RANDOMIZED CLINICAL TRIAL
Same clinical topic · Critical Care